ADVANCED PET IMAGING FOR UROLOGY
Build a High-Performance Prostate Imaging Program, Without Adding Operational Burden
Advanced PET/CT imaging for prostate cancer is rapidly becoming the standard for staging and recurrence detection—yet most urology practices still refer imaging externally, leading to delays, fragmented care, and lost revenue.
THE PROBLEM: What Happens When Imaging Stays Outside Your Practice?
1. American Cancer Society. (2024, September 27). Cancer in men: prostate cancer is #1 for 118 countries worldwide. American Cancer Society. Retrieved from https://www.cancer.org/research/acs-research-news/prostate-cancer-is-number-1-for-118-countries-worldwide.html
THE OPPORTUNITY
Why Urology Practices Are Adopting Advanced PET/CT Imaging?
- Detect metastatic disease with greater precision
- Identify recurrence at very low PSA levels
- Improve surgical and radiation planning
- Guide more effective systemic therapy
- Keep complex cases within your practice
- Accelerate diagnosis and treatment decisions


THE BARRIERS
What’s Holding Most Urology Groups Back?
Bringing advanced PET/CT imaging in-house can be clinically and financially compelling—but the path to implementation is complex.
- High capital investment and unclear ROI
- Complex regulatory and facility requirements
- Radiotracer access and logistics
- Staffing and operational challenges
- Billing, coding, and reimbursement uncertainty
MIS removes the complexity so you can focus on care
A complete, end-to-end molecular imaging program designed specifically for urology practices, backed by decades of experience supporting advanced imaging solutions. Our team brings deep expertise in imaging operations, workflow optimization, and reimbursement, with a proven ability to implement complex programs with minimal disruption. We focus on delivering strong clinical outcomes, operational efficiency, and long-term program success.
PRACTICE IMPACT
What This Means for Your Practice


